BUSINESS

Analyst bullish on Stoke Therapeutics stock following key epilepsy drug data

Moderator - Tomas KauerModerator - Tomas Kauer
Sep 11, 2024 - 14:00
Analyst bullish on Stoke Therapeutics stock following key epilepsy drug data
Read More

Tags:

Previous Article

SciSparc extends $1.85 million loan to Automax

Next Article

CAVA Group stock target raised by Argus on growth opportunities

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Moderator - Tomas Kauer
Moderator - Tomas Kauer

Related Posts

APA Corporation divests Permian assets for $950 million

APA Corporation divests Permian assets for $950 million

Moderator - Tomas... Sep 10, 2024

On TikTok, pop culture prevails over news and politics

On TikTok, pop culture prevails over news and politics

Moderator - Tomas... Oct 8, 2024

Myntra bets on 4-hour delivery amid India’s quick commerce boom

Myntra bets on 4-hour delivery amid India’s quick comme...

Moderator - Tomas... Sep 16, 2024